Global Vaccine Adjuvants Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Scope of the Report:
The classification of vaccine adjuvants includes veterinary vaccine adjuvants and human vaccine adjuvants. And the proportion of human vaccine adjuvants in 2016 is about 52.4%. The veterinary vaccine adjuvants in 2015 are about 47.6%.
The classification of Veterinary Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 56.3%. The Subcutaneous in 2016 is about 29%.
The classification of Human Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 55.5%. The Subcutaneous in 2016 is about 28.8%.

The worldwide market for Vaccine Adjuvants is expected to grow at a CAGR of roughly 10.3% over the next five years, will reach 1010 million US$ in 2024, from 560 million US$ in 2019, according to a new study.
This report focuses on the Vaccine Adjuvants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
SEPPIC
SDA BIO
Brenntag Biosector
SPI Pharma
MVP Laboratories
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL Limited
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Oral
Subcutaneous
Intramuscular
Others

Market Segment by Applications, can be divided into
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Human Vaccine Adjuvants (Research Applications, Commercial Applications)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine Adjuvants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vaccine Adjuvants, with price, sales, revenue and global market share of Vaccine Adjuvants in 2017 and 2018.
Chapter 3, the Vaccine Adjuvants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion, appendix and data source.